Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk and severity of COVID-19 and ABO blood group in transcatheter aortic valve patients

Marion Kibler, Adrien Carmona, Benjamin Marchandot, Kensuke Matsushita, Antonin Trimaille, Mohamad Kanso, Laurent Dietrich, Cécile How-Choong, Albane Odier, Gabrielle Gennesseaux, Ophélie Schramm, Antje Reydel, Michel Kindo, Minh Hoang, Sébastien Hess, Chisato Sato, Sophie Caillard, Laurence Jesel, Olivier Morel, Patrick Ohlmann
doi: https://doi.org/10.1101/2020.06.13.20130211
Marion Kibler
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrien Carmona
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Marchandot
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kensuke Matsushita
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
2INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonin Trimaille
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohamad Kanso
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Dietrich
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cécile How-Choong
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albane Odier
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabrielle Gennesseaux
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ophélie Schramm
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antje Reydel
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Kindo
4Division of Cardiac Surgery, Strasbourg University Hospital, Strasbourg, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minh Hoang
4Division of Cardiac Surgery, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sébastien Hess
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chisato Sato
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Caillard
3Division of Nephrology and Transplantation, Strasbourg University Hospital, Strasbourg, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence Jesel
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
2INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Morel
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
2INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Ohlmann
1Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: patrick.ohlmann@chru-strasbourg.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Although cardiovascular disease has been associated with an increased risk of coronavirus disease 2019 (COVID-19), no studies have reported its clinical course in patients with aortic stenosis who had undergone transcatheter aortic valve replacement (TAVR).

Several observational studies have found an association between the A blood group and an increased susceptibility to SARS-CoV-2 infection, whereas the O blood group appears to be protective.

Objective To investigate the frequency and clinical course of COVID-19 in a large sample of patients who had undergone TAVR and to determine the associations of the ABO blood group with disease occurrence and outcomes.

Methods Patients who had undergone TAVR between 2010 and 2019 were included in this study and followed-up through the recent COVID-19 outbreak. The main outcomes were the occurrence and severity (hospitalization and/or death) of COVID-19 and their association with the ABO blood group.

Results Of the 1125 patients who had undergone TAVR, 403 (36%) died before January 1, 2020, and 20 (1.8%) were lost to follow-up. The study sample therefore consisted of 702 patients. Among them, we identified 22 cases (3.1%) with COVID-19. Fourteen patients (63.6%) were hospitalized or died of disease. Multivariate analysis identified the A blood group (versus others) as the only independent predictor of COVID-19 in patients who had undergone TAVR (odds ratio [OR] = 6.32; 95% confidence interval [CI] = 2.11-18.92; p=0.001). The A blood group (versus others; OR = 8.27; 95% CI = 1.83-37.43, p=0.006) and a history of cancer (OR = 4.99; 95% CI = 1.64-15.27, p = 0.005) were significantly and independently associated with disease severity (hospitalization and/or death).

Conclusions Patients who had undergone TAVR are vulnerable to COVID-19. The subgroup with the A blood group was especially prone to develop the disease and showed unfavorable outcomes.

Condensed abstract Among 702 patients who had undergone TAVR between 2010 and 2019 and who were alive on January 1, 2020, 22 patients developed COVID-19. Fourteen patients (63.6%) were hospitalized or died of disease. The A blood group (versus others) was the only independent predictor of COVID-19. The A blood group and a history of cancer were significantly and independently associated with disease severity (hospitalization and/or death). Altogether these findings suggest that patients who had undergone TAVR are vulnerable to COVID-19. The subgroup with the A blood group was especially prone to develop the disease and showed unfavorable outcomes.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was reviewed and approved by the Institutional Review Board at the Strasbourg University Hospital (CE-2020-69)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The database is available online with the link below

https://www.dropbox.com/s/cdny37mtajzp0cs/BDD%20COVID%20TAVI%20V1.xlsx?dl=0

  • Abbreviations

    ACE-2
    Angiotensin converting enzyme 2
    COVID-19
    coronavirus disease 2019
    CT
    Computed tomography
    CV
    Cardiovascular
    Rh
    Rhesus
    RT-PCR
    Reverse transcriptase Polymerase Chain reaction
    SARS-CoV-2
    Severe Acute Respiratory Coronavirus-2
    TAVR
    Transcatheter aortic valve replacement
    WHO
    World Health Organization
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted June 16, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Risk and severity of COVID-19 and ABO blood group in transcatheter aortic valve patients
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Risk and severity of COVID-19 and ABO blood group in transcatheter aortic valve patients
    Marion Kibler, Adrien Carmona, Benjamin Marchandot, Kensuke Matsushita, Antonin Trimaille, Mohamad Kanso, Laurent Dietrich, Cécile How-Choong, Albane Odier, Gabrielle Gennesseaux, Ophélie Schramm, Antje Reydel, Michel Kindo, Minh Hoang, Sébastien Hess, Chisato Sato, Sophie Caillard, Laurence Jesel, Olivier Morel, Patrick Ohlmann
    medRxiv 2020.06.13.20130211; doi: https://doi.org/10.1101/2020.06.13.20130211
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Risk and severity of COVID-19 and ABO blood group in transcatheter aortic valve patients
    Marion Kibler, Adrien Carmona, Benjamin Marchandot, Kensuke Matsushita, Antonin Trimaille, Mohamad Kanso, Laurent Dietrich, Cécile How-Choong, Albane Odier, Gabrielle Gennesseaux, Ophélie Schramm, Antje Reydel, Michel Kindo, Minh Hoang, Sébastien Hess, Chisato Sato, Sophie Caillard, Laurence Jesel, Olivier Morel, Patrick Ohlmann
    medRxiv 2020.06.13.20130211; doi: https://doi.org/10.1101/2020.06.13.20130211

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (271)
    • Allergy and Immunology (557)
    • Anesthesia (135)
    • Cardiovascular Medicine (1769)
    • Dentistry and Oral Medicine (238)
    • Dermatology (173)
    • Emergency Medicine (316)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
    • Epidemiology (10812)
    • Forensic Medicine (8)
    • Gastroenterology (594)
    • Genetic and Genomic Medicine (2960)
    • Geriatric Medicine (288)
    • Health Economics (534)
    • Health Informatics (1933)
    • Health Policy (836)
    • Health Systems and Quality Improvement (745)
    • Hematology (293)
    • HIV/AIDS (633)
    • Infectious Diseases (except HIV/AIDS) (12525)
    • Intensive Care and Critical Care Medicine (696)
    • Medical Education (300)
    • Medical Ethics (87)
    • Nephrology (324)
    • Neurology (2808)
    • Nursing (152)
    • Nutrition (433)
    • Obstetrics and Gynecology (559)
    • Occupational and Environmental Health (597)
    • Oncology (1473)
    • Ophthalmology (444)
    • Orthopedics (172)
    • Otolaryngology (257)
    • Pain Medicine (190)
    • Palliative Medicine (56)
    • Pathology (381)
    • Pediatrics (868)
    • Pharmacology and Therapeutics (367)
    • Primary Care Research (338)
    • Psychiatry and Clinical Psychology (2646)
    • Public and Global Health (5383)
    • Radiology and Imaging (1016)
    • Rehabilitation Medicine and Physical Therapy (597)
    • Respiratory Medicine (727)
    • Rheumatology (330)
    • Sexual and Reproductive Health (290)
    • Sports Medicine (279)
    • Surgery (327)
    • Toxicology (48)
    • Transplantation (150)
    • Urology (126)